TABLE 4.

Effect of BSTN1 on FBG, PPBG, F-Ins and HOMA-IR in treated and untreated rats.

Parameters	Normal control	HFD control	BSTN1-1.25 mg	BSTN1-2.5 mg	BSTN1-5 mg	ORL-5 mg
FBG (mg/dl)	86.12 ± 4.6	159.6 ± 8.0#	133.0 ± 6.1*	115.1 ± 9.2**	91.2 ± 7.1***	97.3 ± 6.9***
PPBG (mg/dl)	99.6 ± 5.0	211.1 ± 9.4#	174.6 ± 3.7*	141.5 ± 8.7**	100.3 ± 5.7***	104.7 ± 3.9***
F-Ins (µIU/ml)	14.57 ± 1.8	18.07 ± 1.3#	15.33 ± 2.1*	15.09 ± 2.0**	14.72 ± 1.7***	14.94 ± 1.1***
HOMA-IR	3.1	7.1#	5.0*	4.3**	3.3***	3.6***

^# p < 0.001 indicates significant difference between HFD control and normal control. *, ** and *** indicate significant difference between HFD control and treated groups at p < 0.05, p < 0.01, and p < 0.001, respectively. FBG, fasting blood glucose; PPBG, post-prandial blood glucose; F-Ins, fasting insulin; HOMA-IR, homeostasis model assessment index for insulin resistance.